Table of Content



Introduction
Primary Sclerosing Cholangitis - Overview
Primary Sclerosing Cholangitis - Therapeutics Development
Primary Sclerosing Cholangitis - Therapeutics Assessment
Primary Sclerosing Cholangitis - Companies Involved in Therapeutics Development
Primary Sclerosing Cholangitis - Drug Profiles
Primary Sclerosing Cholangitis - Dormant Projects
Primary Sclerosing Cholangitis - Discontinued Products
Primary Sclerosing Cholangitis - Product Development Milestones
Appendix



List of Figures



Number of Products under Development for Primary Sclerosing Cholangitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables



Number of Products under Development for Primary Sclerosing Cholangitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Albireo Pharma Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Allergan Plc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by BiomX Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by ChemomAb Ltd, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Dr. Falk Pharma GmbH, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Emergent Biotechnologies LLC, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Engitix Ltd, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Gilead Sciences Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Immunic Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Intercept Pharmaceuticals Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Mirum Pharmaceuticals Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Morphic Holding Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by NGM Biopharmaceuticals Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Nyrada Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Orbsen Therapeutics Ltd, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Pliant Therapeutics Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Qing Bile Therapeutics Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Seres Therapeutics Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Shenzhen HighTide Biopharmaceutical Ltd, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Sirnaomics Inc, H1 2020
Primary Sclerosing Cholangitis - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2020
Primary Sclerosing Cholangitis - Dormant Projects, H1 2020
Primary Sclerosing Cholangitis - Discontinued Products, H1 2020